In the dynamic field of pharmaceutical development, the availability of high-quality, reliable chemical intermediates is paramount. Among these crucial compounds, 1,2,3,4-Tetrahydro-4-oxo-carbazole, identified by its CAS number 206647-27-0, stands out for its versatility and utility.

This heterocyclic compound, with a molecular formula of C12H11NO and a molecular weight of 185.22200, serves as a fundamental building block in the synthesis of various active pharmaceutical ingredients (APIs). Its stable structure and specific reactivity make it an attractive choice for organic chemists engaged in complex synthesis pathways.

The stringent purity requirements of the pharmaceutical industry necessitate reliable suppliers. Manufacturers like us, based in China, are dedicated to providing 1,2,3,4-Tetrahydro-4-oxo-carbazole with a minimum purity of 95%. This ensures that researchers and production facilities can trust the consistency and quality of the material for their critical applications.

Beyond its role as a direct intermediate, 1,2,3,4-Tetrahydro-4-oxo-carbazole is also a valuable tool in early-stage drug discovery. Its carbazole core can be modified to explore novel molecular scaffolds with potential therapeutic benefits across various disease areas. The ability to purchase this compound in convenient packaging sizes, from grams to kilograms, further supports both laboratory-scale research and larger production needs.

For procurement professionals and R&D scientists seeking to buy this essential pharmaceutical intermediate, understanding the technical specifications is key. Information regarding its boiling point (335.657ºC at 760 mmHg) and flash point (145.106ºC) provides crucial safety and handling data. Furthermore, working with a reputable manufacturer offers the advantage of competitive pricing and the potential for free samples, facilitating a smooth purchasing process.

In conclusion, 1,2,3,4-Tetrahydro-4-oxo-carbazole (CAS 206647-27-0) is more than just a chemical; it's an enabler of pharmaceutical innovation. By partnering with experienced manufacturers, the industry can ensure a consistent and high-quality supply, driving forward the development of life-saving medicines.